Real-World Effectiveness of Gliclazide MR vs. Sitagliptin as Second-Line Therapy in People with Type 2 Diabetes Uncontrolled on Metformin

被引：0
|
作者：
Zaccardi, Francesco
Cortese, Viviana
Jacquot, Emmanuelle
Tyrer, Freya
Seidu, Samuel
Davies, Melanie J.
Khunti, Kamlesh
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1062-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1062-P
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
    Kamlesh Khunti
    Mohamed Hassanein
    Moon-Kyu Lee
    Viswanathan Mohan
    Aslam Amod
    Diabetes Therapy, 2020, 11 : 33 - 48
  • [32] EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
    Gomez-Dominguez, Elena
    Montero, Jose-Luis
    Molina, Esther
    Casado, Marta
    Garcia-Buey, Maria Luisa
    Simon, Miguel Angel
    Fuentes, Javier
    Diaz-Gonzalez, Alvaro
    Berenguer, Marina
    Conde, Isabel
    Garrido, Isabel
    Macedo, Guilherme
    Jorquera, Francisco
    Morillas, Rosa Maria
    Presa, Jose Antonio
    Rodriguez-Tajes, Sergio
    Olivas, Ignasi
    Londono, Maria Carlota
    Ampuero, Javier
    Romero-Gonzalez, Eva
    Gonzalez-Padilla, Sheila
    Escudero-Garcia, Desamparados
    Martin, Jose Manuel Sousa
    Gomes, Dario Lorga
    Santos, Luis
    Olveria, Antonio
    Hernandez-Guerra, Manuel
    Santos, Manuel A.
    Carvalho, Armando S. P.
    Uriz, Juan
    Gutierrez, Maria Luisa
    Quinones, Marta
    Perez, Elia
    Martinez, Javier
    Albillos, Agustin
    Fernandez-Rodriguez, Conrado
    HEPATOLOGY, 2023, 78 : S116 - S117
  • [33] Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
    DeFronzo, Ralph A.
    Lewin, Andrew
    Patel, Sanjay
    Liu, Dacheng
    Kaste, Renee
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES CARE, 2015, 38 (03) : 384 - 393
  • [34] Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study
    Dang-Tan, Tam
    Kamble, Pravin S.
    Meah, Yunus
    Gamble, Cory
    Ganguly, Rahul
    Horter, Libby
    DIABETES THERAPY, 2020, 11 (01) : 213 - 228
  • [35] Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study
    Tam Dang-Tan
    Pravin S. Kamble
    Yunus Meah
    Cory Gamble
    Rahul Ganguly
    Libby Horter
    Diabetes Therapy, 2020, 11 : 213 - 228
  • [36] REAL WORLD CLINICAL EFFECTIVENESS OF SITAGLIPTIN THERAPY FOR MANAGEMENT OF TYPE 2 DIABETES: A RETROSPECTIVE DATABASE ANALYSIS
    Wade, R.
    Pawaskar, M. D.
    Quimbo, R. A.
    Hou, L.
    VALUE IN HEALTH, 2009, 12 (07) : A401 - A401
  • [37] COMPARATIVE EFFECTIVENESS ON CARDIOVASCULAR OUTCOMES OF METFORMIN INITIAL THERAPY AND ADD-ON SECOND-LINE DRUGS AMONG PATIENTS WITH TYPE 2 DIABETES
    Kim, Y.
    Ko, M.
    Jo, A.
    Kang, S.
    Tchoe, H.
    Park, C.
    Kim, H.
    Choi, J.
    Park, D.
    Lee, W.
    VALUE IN HEALTH, 2015, 18 (07) : A382 - A382
  • [38] Quality of Life in People with Type 2 Diabetes following Initiation of Second-Line Therapy: DISCOVER
    Nicolucci, Antonio
    Chen, Hungta
    Cooper, Andrew
    Gomes, Marilia B.
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail N.
    Leigh, Paul
    Ramirez, Larisa
    Shestakova, Marina V.
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Arnold, Suzanne V.
    DIABETES, 2020, 69
  • [39] The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
    Khunti, Kamlesh
    Almalki, Mussa
    Chan, Juliana C. N.
    Amod, Aslam
    DIABETES THERAPY, 2023, 14 (10) : 1609 - 1625
  • [40] Cost-effectiveness of adding sitagliptin vs. an sulfonylurea in Swiss patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Brandle, M.
    Chen, J.
    Alemao, E.
    Yin, D.
    Cook, J.
    Szucs, T.
    DIABETOLOGIA, 2008, 51 : S446 - S446
12345